NHS, endometriosis and Ryeqo

New endometriosis pill: How does endometriosis drug Ryeqo work, and is it available on the NHS in Scotland?
Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS in England and Wales.
'Transformational' pill for endometriosis gets NHS nod
Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap (leuprorelin acetate) and AstraZeneca's Zoladex (goserelin acetate) – which are only licensed for up to six months – can be taken up until menopause.
Daily endometriosis pill Ryeqo to be made available on NHS in Wales
Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can access it
Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS
We believe quality journalism should be available to everyone, paid for by those who can afford it. A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people in England suffering from the debilitating condition.
NHS approves long-term daily pill for endometriosis in England
The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), the first long-term pill available for endometriosis, marking a significant breakthrough in treatment.
New endometriosis pill approved for use on NHS in breakthrough for women's health
A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS. The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition.
Finally, an endometriosis pill is available on the NHS – here's everything you need to know
Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what's being a called a “first-of-its-kind” step forward in treating the debilitating disease.
New endometriosis pill approved on NHS in England
The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England - but only for patients who have tried all other options. Endometriosis affects 1.5 million women in the UK,
'First-of-a-kind' pill for endometriosis is approved by the NHS – but is it really a miracle drug?
Managing debilitating symptoms for a condition that has no cure or universal treatment is almost impossible – and it's the reality for the 1.5 million women and those born female with endometriosis in the UK.
NHS approve new pill that will 'transform' the treatment of endometriosis
The NHS has approved a new pill that is designed to transform the treatment of endometriosis. The combination drug will help around 1,000 women every year in England who suffer from the debilitating condition.
A New Pill Will Soon Be Available For Endometriosis Patients – Here’s What You Should Know
Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...
Stylist2d
A new treatment for endometriosis is finally available on the NHS – here’s what you need to know
The new tablet, known as Ryeqo or relugolix-estradiol-norethisterone, has been approved to treat women of reproductive age ...
Breakthrough endometriosis treatment approved for NHS use offers hope to thousands
The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that ...
The Independent2d
Endometriosis: What to know about debilitating condition as new pill approved for NHS
This marks the first long-term, daily oral treatment for the condition, offering a significant advancement in endometriosis management. Ryeqo works by blocking hormones that contribute to ...
‘First-of-a-kind’ daily pill for agonising condition will be available on NHS – in breakthrough for millions
A FIRST-of-its-kind pill designed to transform treatment of agonising endometriosis will be available on the NHS. The condition affects an estimated 1.5 million women in the UK, causing intense ...